February 2, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of INUVO INC (AMEX:INUV), CEREPLAST INC (OTCBB:CERP), APCO OIL AND GAS INTL INC (NASDAQ:APAGF), CANADIAN SOLAR INC (NASDAQ:CSIQ), ARCA BIOPHARMA INC (NASDAQ:ABIO), GENTIUM SPA-SPONSORED ADR (NASDAQ:GENT) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     INUV       INUVO INC                           -19.12%             84.62% (11 of 13)       Wednesday, February 22nd 2012
     CERP       CEREPLAST INC                       -13.85%             66.67% (4 of 6)         Monday, March 12th 2012
     APAGF      APCO OIL AND GAS INTL INC           -3.23%              100.00% (11 of 11)      Tuesday, February 7th 2012
     CSIQ       CANADIAN SOLAR INC                  -15.01%             100.00% (5 of 5)        Thursday, March 15th 2012
     ABIO       ARCA BIOPHARMA INC                  -14.96%             75.00% (9 of 12)        Wednesday, March 14th 2012
     GENT       GENTIUM SPA-SPONSORED ADR           -17.70%             66.67% (4 of 6)         Tuesday, March 13th 2012

INUVO INC (AMEX:INUV) - Inuvo, Inc., an Internet marketing services company, provides marketing and technology solutions to businesses and individuals. It develops software and analytics technology that is accessible over the Internet for use by online advertisers and Website publishers. The company operates in two segments, Exchange and Direct. The Exchange segment designs, builds, implements, manages, and sells various technology platforms and services. This segment offers Inuvo Platform, a lead generation marketplace that helps advertisers and publishers to manage their transactions in an automated and transparent environment. Its platforms also include ValidClick, a pay-per-click marketplace; MyAP Affiliate, an affiliate tracking and management software solution; LocalXML, a service that allow publishers to make real-time calls to the LocalXML database; Yellowise.com, a local search and review site; and Zubican, a business directory. The Direct segment designs, builds, and implements unique offers and/or Websites that helps in the sale of products, services, data, and advertising. It manages owned and operated properties across verticals that include professional recertification and baby products. This segments properties include babytobee.com, a Website that collects and sells leads for or to merchants of products that target expectant parents or families with children; PrimaryAds, a lead generation network matching high converting, high-paying offers from advertisers to high-quality traffic and leads through a network of select affiliates; and Real Estate School Online that sells accredited real estate licensing courses, real estate continuing education courses, and online CD-ROM or correspondence real estate exam prep courses in 40 states. The company was formerly known as Kowabunga! Inc. and changed its name to Inuvo, Inc. in July 2009. Inuvo, Inc. is headquartered in Clearwater, Florida.

CEREPLAST INC (OTCBB:CERP) - Cereplast, Inc. develops and commercializes bio-based resins in the United States. The companys product includes Cereplast Compostables resins, which is substitutes for petroleum-based plastics targeting primarily single-use disposables and packaging applications. It also offers Cereplast Hybrid Resins that replace up to 50% of the petroleum content in conventional plastics with bio-based materials, such as industrial starches sourced from plants for use in a range of markets, including automotive, consumer goods, consumer electronics, medical, packaging, and construction. The companys resins are also used in various conventional converting processes, including injection molding, thermoforming, blow film, blow molding, and extrusion. Its developing product also includes Cereplast Algae Plastics to transform algae into bioplastics. The company was formerly known as Biocorp North America Inc. and changed its name to Cereplast, Inc. in March 2005. Cereplast, Inc. was incorporated in 2001 and is headquartered in El Segundo, California.

APCO OIL AND GAS INTL INC (NASDAQ:APAGF) - Apco Oil and Gas International Inc. operates as an oil and gas exploration and production company with a focus on South America. The companys principal concessions include Entre Lomas, Bajada del Palo, and Charco del Palenque concessions located in the Neuquen basin, Argentina; and the Agua Amarga exploration permit situated in the Neuquen basin, Argentina. As of December 31, 2009, it has interests in nine oil and gas producing concessions and one exploration permit in Argentina, as well as two exploration and production contracts in Colombia. The company was formerly known as Apco Argentina Inc. and changed its name to Apco Oil and Gas International Inc. in July 2009. The company was founded in 1970 and is headquartered in Tulsa, Oklahoma. Apco Oil and Gas International Inc. is a subsidiary of Williams Companies, Inc.

CANADIAN SOLAR INC (NASDAQ:CSIQ) - Canadian Solar Inc. engages in the design, development, manufacture, and marketing of solar power products primarily in Canada and internationally. The company offers solar cell and solar module products that convert sunlight into electricity for various uses. Its products include a range of standard solar modules for use in a range of residential, commercial, and industrial solar power generation systems. The company also designs and produces specialty solar modules and products consisting of customized modules that its customers incorporate into their products, such as solar-powered bus stop lighting; and specialty products, such as portable solar home systems and solar-powered car battery chargers. In addition, it implements solar power development projects, primarily in conjunction with government organizations to provide solar power generation in rural areas of China. The company sells its products under the Canadian Solar brand name. It offers its standard solar modules through a direct sales force and sales agents primarily to distributors, system integrators, and original equipment manufacturer customers, as well as to solar projects; and specialty solar modules and products to the automotive, telecommunications, and LED lighting sectors. The company was founded in 2001 and is based in Kitchener, Canada.

ARCA BIOPHARMA INC (NASDAQ:ABIO) - ARCA biopharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of genetically-targeted therapies for heart failure and other cardiovascular diseases in the United States. The companys lead product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator for the treatment of chronic heart failure and other indications. Its development pipeline includes rNAPc2, a long-acting recombinant protein anticoagulant with a mechanism of action involving inhibition of tissue factor; and NU172, a short-acting anticoagulant, under collaboration agreement with Archemix Corporation, used during medical or surgical procedures. ARCA biopharma has a collaboration agreement with Laboratory Corporation of America to develop the genetic test for Gencaro. The company is headquartered in Broomfield, Colorado.

GENTIUM SPA-SPONSORED ADR (NASDAQ:GENT) - Gentium S.p.A., a biopharmaceutical company, focuses on the development and manufacture of drugs to treat and prevent various diseases and conditions, including vascular diseases related to cancer and cancer treatments. It develops and manufactures defibrotide, a drug based on single-stranded DNA extracted from pig intestines to treat and prevent hepatic veno-occlusive disease (VOD), a condition in which some of the veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation treatments that are given prior to stem cell transplantation. The company has completed a Phase III clinical trial of defibrotide for the treatment of severe VOD in the United States, Canada, and Israel; and a Phase II/III pediatric trial in Europe for the prevention of VOD in children. It also offers sulglicotide that is developed from swine duodenum, and has ulcer healing and gastrointestinal protective properties in South Korea; and urokinase, which is made from human urine to treat various vascular disorders, such as deep vein thrombosis and pulmonary embolisms. The company was formerly known as Pharma Research S.r.L. and changed its name to Gentium S.p.A. in July 2001. Gentium S.p.A. was founded in 1993 and is headquartered in Villa Guardia, Italy.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

Like: 👍